This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Aventis Pharma S.a.. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: François Hamy: Innovator in Cancer Therapy
Introduction
François Hamy is a notable inventor based in Illzach, France. He has made significant contributions to the field of cancer therapy through his innovative research and development of novel chemical compounds.
Latest Patents
Hamy holds a patent for "Triazine derivatives and their application as antitelomerase agents." This invention relates to cancer therapy and introduces novel anticancer agents that operate through a specific mechanism of action. The patent also encompasses new chemical compounds and their therapeutic applications in humans. He has 1 patent to his name.
Career Highlights
François Hamy is associated with Aventis Pharma S.A., where he has been instrumental in advancing cancer treatment methodologies. His work focuses on developing effective therapeutic agents that target cancer cells.
Collaborations
Hamy has collaborated with notable colleagues, including Patrick Mailliet and Abdelazize Laoui, to further enhance the research and development of cancer therapies.
Conclusion
François Hamy is a dedicated inventor whose work in cancer therapy has the potential to make a significant impact on treatment options for patients. His innovative approach and collaboration with other experts in the field highlight his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile